ACER3 promotes the growth of hepatocellular carcinoma cells through the S1P/S1PR2/PI3K/AKT signaling pathway and may be a potential therapeutic target for the treatment of liver cancers (Yin et al., 2018). Here, ACER3 is linked to hepatocellular carcinoma.